Cambridge, United Kingdom

Lai Chun Chan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 21.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Lai Chun Chan: A Notable Contributor to Pharmaceutical Processes

Introduction

Lai Chun Chan, an inventive mind based in Cambridge, GB, has made significant strides in the field of pharmaceutical chemistry. His work primarily focuses on the development of improved processes for the preparation of complex chemical compounds, reflecting a commitment to innovation in the industry.

Latest Patents

Lai Chun Chan holds a patent related to the processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}N-(pyridin-2-yl)-benzamide. This patent discusses enhanced methods for manufacturing this specific compound and its intermediates, emphasizing large-scale production capabilities. The advancements presented are crucial in optimizing manufacturing efficiency and ensuring quality in pharmaceutical development.

Career Highlights

Currently, Lai Chun Chan is associated with Acerta Pharma B.V., where he utilizes his expertise to drive research and development efforts. His contributions significantly enhance the capabilities of the company in pharmaceutical innovation and production. With a focus on efficiency and effectiveness, Lai's work stands as a testament to the vital role of inventors in advancing scientific boundaries.

Collaborations

Throughout his career, Lai Chun Chan has collaborated with other talented professionals, including Paul Allen Bethel and Katie Grace Cooper. These partnerships illustrate the collaborative nature of research and innovation in the pharmaceutical industry, fostering an environment where ideas and expertise converge to create groundbreaking solutions.

Conclusion

Lai Chun Chan's contributions to the field of pharmaceutical processes showcase the importance of innovation in the development of new treatments. His patent highlights the potential for improved manufacturing techniques that can benefit various sectors within the industry. As a member of Acerta Pharma B.V., his work continues to inspire future advancements in pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…